Who Owns BIAFW?

bioAffinity Technologies, Inc. Warrant — Institutional Ownership & 13F Holdings

$0.33

+0.00 (+0.00%)

Market Cap

$1.1M

Shares Outstanding

4,498,675

Institutional Holders

4

Total Inst. Value

$10.5B

% of Float Held

QoQ Holder Change

-1

Institutional data as of Q1 2025

New Positions

0

Closed Positions

2

Increased

1

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CLEAR STREET LLC$10.5B55,122
2ARMISTICE CAPITAL, LLC$39K204,082
3UBS Group AG$9K48,283
4CITADEL ADVISORS LLC$7K35,988

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
UBS Group AG+48K$9K

Top Sellers

FundShares RemovedValue
CITADEL ADVISORS LLC-14K$7K
CLEAR STREET LLC-11$10.5B

Related Stocks

Frequently Asked Questions

How many institutional investors hold BIAFW?

As of Q1 2025, 4 institutional investors report holding BIAFW (bioAffinity Technologies, Inc. Warrant) in their 13F filings.

Which hedge fund owns the most BIAFW?

The largest institutional holder of BIAFW is CLEAR STREET LLC with $10.5B in shares.

Are institutions buying or selling BIAFW?

This quarter, 0 institutions opened new positions in BIAFW and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.